Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: And finally with S&L down to under 7 million shares as of 2/17
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: And finally with S&L down to under 7 million shares as of 2/17
The effective date of S & L's filing was their fiscal year ended 12/31/08, not the filing date of 2/17/90. The time difference gave S & L an additional 2 1/2 months to unload shares.